The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction

NCT02081781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2014-03-07

No results posted yet for this study

Summary

The purpose of this study was to investigate various potential factors that affected the outcome of treatment of congenital nasolacrimal duct obstruction.

Conditions

  • Congenital Nasolacrimal Duct Obstruction

Interventions

PROCEDURE

Probing

A punctal dilator was used for dilating the punctum. The nasolacrimal system was irrigated through either the lower or upper punctum with a hollow 23-gauge irrigating cannula attached to a syringe. A #0 (or #00) Bowman probe was passed through either the lower or upper canaliculus into the lacrimal sac and then directed downward through the nasolacrimal duct into nasal cavity. A "Hard" resistance could be felt as the probe touched the end of the nasolacrimal duct. A "Pop" tactile sensation might be noted while the probe passing through an obstruction at the valve of Hasner.

Sponsors & Collaborators

  • Cathay General Hospital

    lead OTHER

Principal Investigators

  • Chih Heng Hung, M.D. · Department of Ophthalmology, Cathay General Hospital

Eligibility

Min Age
1 Week
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02081781 on ClinicalTrials.gov